Holen Sie sich die Stockscreener-App
2.15
25.61%
-0.74
Handel nachbörslich:
2.20
0.05
+2.33%
Schlusskurs vom Vortag:
$2.89
Offen:
$2.43
24-Stunden-Volumen:
8.32M
Relative Volume:
3.04
Marktkapitalisierung:
$430.79M
Einnahmen:
$216.56M
Nettoeinkommen (Verlust:
$-9.57M
KGV:
-43.26
EPS:
-0.0497
Netto-Cashflow:
$-1.22M
1W Leistung:
-26.62%
1M Leistung:
-26.37%
6M Leistung:
-7.73%
1J Leistung:
+67.97%
1-Tages-Spanne:
$2.06
$2.46
1-Wochen-Bereich:
$2.06
$3.13
52-Wochen-Spanne:
$1.15
$3.4698
Cerus Corp Stock (CERS) Company Profile
Firmenname
Cerus Corp
Sektor
Branche
Telefon
(925) 288-6000
Adresse
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
2.15 | 615.13M | 216.56M | -9.57M | -1.22M | -0.0497 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-12 | Eingeleitet | Craig Hallum | Buy |
| 2023-01-20 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-01-17 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-02-26 | Eingeleitet | BTIG Research | Buy |
| 2019-11-13 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-08-28 | Eingeleitet | Stifel | Buy |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-12-08 | Fortgesetzt | BTIG Research | Neutral |
| 2016-07-07 | Fortgesetzt | Cantor Fitzgerald | Buy |
| 2015-12-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2014-05-02 | Bestätigt | MLV & Co | Buy |
| 2013-04-24 | Bestätigt | Cantor Fitzgerald | Buy |
| 2013-03-15 | Bestätigt | MLV & Co | Buy |
| 2012-04-17 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2012-02-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | Bestätigt | MLV & Co | Buy |
| 2011-06-03 | Eingeleitet | Wedbush | Outperform |
| 2011-03-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | Hochstufung | Avondale | Mkt Perform → Mkt Outperform |
Alle ansehen
Cerus Corp Aktie (CERS) Neueste Nachrichten
CERS|Cerus Corp|Price:3.065|Chg%:+0.135 - TradingKey
Cerus Corp (CERS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cerus Corp (CERS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cerus Corp (CERS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cerus Corp (CERS) Cash Flow - TradingKey
Cerus Corp (CERS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Cerus Corp (CERS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cerus Corp (CERS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cerus (CERS) to Announce Quarterly Earnings on Thursday - MarketBeat
Cerus Corp (CERS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AlTi Global Leads Our Selection Of 3 Promising Penny Stocks - simplywall.st
Cerus Corp (CERS) CEO trades 16666 shares under 10b5-1 plan - Stock Titan
Cerus Corporation (CERS) Edges Higher as Stock Holds Above Key SupportDiagonal Spread Trade - dars.gov.et
Cerus Corporation (NASDAQ:CERS) Short Interest Down 35.3% in June - MarketBeat
CERS: Cerus Corp. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Press Release: Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026 - Moomoo
Cerus Corporation to release Q2 2026 results on July 30 - scanx.trade
CERS shareholder (NASDAQ: CERS) details planned stock sales in 2026 - Stock Titan
Cerus to Discuss Results and Outlook in July 30 Webcast - Stock Titan
Cerus Corporation Announces Executive Chairman Transition and Employment Agreement Amendment – SEC 8-K Filing July 2026 - Minichart
Cerus Corporation (CERS) defines pay and term for William Greenman as Executive Chairman - Stock Titan
Cerus Corp faces a complex landscape as blood safety technology evolves - Ad-hoc-news.de
ETFs Investing in Cerus Corporation Stocks - TradingView
Cerus Corp updates focus on blood safety. Business model supports long-term growth - Ad-hoc-news.de
Cerus Corp looks to blood safety technology as investors weigh long-term growth - ad-hoc-news.de
Cerus Company Profile & Introduction - Moomoo
CERSCerus Corp Latest SEC Filings - Finviz
CERS Should I Buy - Intellectia AI
Cerus CEO William Greenman sells $299,937 in common stock - Investing.com UK
Cerus Corp chief legal officer Chrystal Jensen sells $71,597 in stock - Investing.com Nigeria
Cerus CFO Kevin Green sells $99,105 in CERS shares - Investing.com
Cerus COO Vivek Jayaraman disposes of $124,658 in stock for taxes - Investing.com
Cerus CFO Kevin Green sells $99,105 in CERS shares By Investing.com - Investing.com Nigeria
Form 4 Cerus Corporation For: 2 July By Investing.com - Investing.com Canada
Cerus CEO William Greenman sells $299,937 in common stock By Investing.com - Investing.com Canada
Cerus (CERS) CFO logs tax-related share sale and new stock grant - Stock Titan
Cerus (CERS) COO granted RSUs, performance rights and sells shares - Stock Titan
Cerus (NASDAQ: CERS) CLO reports Rule 10b5-1 tax sale and 55,000-share grant - Stock Titan
CERUS (CERS) CEO Greenman logs tax-related share sale and 192,500-share grant - Stock Titan
Cerus Corporation (CERS) Surges 9.66%: Testing Resistance Near $3.04Large Cap Trends - dars.gov.et
Cerus Corp (CERS) Institutional Confidence - TradingKey
Cerus StockFriday sector check and transfusion focus - AD HOC NEWS
CERUS CORP (CERS) Stock Chart - ChartMill
Cerus Corp (CERS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cerus takes INTERCEPT blood system data to global transfusion congress - Stock Titan
Cerus Corporation (CERS) Closes New Debt Facility of Up to $110M - Insider Monkey
5 Best Genomics Stocks to Buy According to Analysts - Insider Monkey
Cerus Corporation (NASDAQ:CERS) Sees Significant Decrease in Short Interest - MarketBeat
Cerus Corp director Eric Bjerkholt sells $53,180 in stock By Investing.com - Investing.com Australia
Director Eric Bjerkholt Sells 20,454 Shares of Cerus Corp (CERS) - GuruFocus
Finanzdaten der Cerus Corp-Aktie (CERS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):